Morphine, the NMDA receptor antagonist MK801 and the tachykinin NK1 receptor antagonist RP67580 attenuate the development of inflammation-induced progressive tactile hypersensitivity.

Source:http://linkedlifedata.com/resource/pubmed/id/9755018

Download in:

View as

General Info

PMID
9755018